Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
60.9% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
4
users have commented on this narrative
46
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
31.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
25
users have liked this narrative
5
users have commented on this narrative
68
users have followed this narrative
New
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
19.7% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
1
users have commented on this narrative
8
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Coca-Cola
ST
StjepanK
Equity Analyst and Writer
Coca-Cola Can Draw Minor Benefits from Prolonged Economic Uncertainty
Key Takeaways Coca-Cola is the leading global brand, and it has endured numerous market downturns with its tested business model. The firm's stability, which includes over six decades of raising its dividend and a share price that is half as volatile as the average market, appeals to a certain investor population.
View narrative
US$71.00
FV
2.7% undervalued
intrinsic discount
6.64%
Revenue growth p.a.
Set Fair Value
9
users have liked this narrative
7
users have commented on this narrative
19
users have followed this narrative
4 months ago
author updated this narrative
Salesforce
GO
Goran_Damchevski
Equity Analyst
Salesforce Is Solidifying Its Leadership With Enterprise Cloud Customers But Market Growth Expectations Are High
Key Takeaways The CRM landscape is shifting to specialized CRMs for different use cases There is room to increase its market share to 20%. Most efficiency gains have been made, and excess capital will return to shareholders Salesforce will leverage its cloud to create an attractive value proposition.
View narrative
US$223.99
FV
10.5% overvalued
intrinsic discount
13.00%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
1
users have commented on this narrative
24
users have followed this narrative
8 months ago
author updated this narrative
Johnson & Johnson
GO
Goran_Damchevski
Equity Analyst
Rich Drug Pipeline Will Push Revenues and Earnings Higher
Key Takeaways Well-diversified drug pipeline with 52 drugs in late-stage approval - a good hedge for its patent expirations Kenvue spin off allows JNJ to focus on its more profitable Medical Devices and Pharmaceuticals segments Continued dividend increases and buybacks are affordable and will help capital returns Post Kenvue, I expect JNJ to grow revenues by 7.5% p.a. from its new baseline of $84B, and at higher margins Some risks around litigation, patent expiry and drug success are present Catalysts Robust Drug Pipeline: 52 Drugs Racing To The Finish Line In Late-Stage Approval The key threat to a pharmaceutical stock is the patent expiration of their high value assets. Should a company lack a product pipeline to bolster its future product portfolio, then losing exclusivity to any one drug can be a hit to the business.
View narrative
US$173.55
FV
1.6% undervalued
intrinsic discount
6.30%
Revenue growth p.a.
Set Fair Value
16
users have liked this narrative
1
users have commented on this narrative
22
users have followed this narrative
9 months ago
author updated this narrative
PayPal Holdings
ST
StjepanK
Equity Analyst and Writer
PayPal’s Strong Branding Can Take Advantage Of E-Commerce Tailwind
Key Takeaways PayPal is the online payments household brand benefiting from the positive trend in the E-commerce industry. Venmo’s sub-brand is a growth driver, which could reach over $2 billion in annual revenue by 2027.
View narrative
US$111.57
FV
39.2% undervalued
intrinsic discount
5.00%
Revenue growth p.a.
Set Fair Value
104
users have liked this narrative
7
users have commented on this narrative
32
users have followed this narrative
4 months ago
author updated this narrative
Tesla
GO
Goran_Damchevski
Equity Analyst
Decent Revenue Growth Won't Stop Valuation Multiple Re-rating Lower
Key Takeaways Tesla’s auto market share will grow but less than investors expect The semi will contribute $17.5B if its value proposition matches that of ICE trucks Energy revenues will reach $16.7B in 2028 as industry tailwinds support continued growth If FSD wins, it’s at risk of being shared by government safety mandates PE will re-rate lower in long term to be similar to current auto peers Business has great growth prospects, but even they don’t justify current price Catalysts Tesla’s TAM and Market Share Has Limitations In the last 4 quarters ending Q2’23, Tesla has delivered 1,638,123 vehicles. Approximately 46.8% of total sales are made in the U.S. and we can use this as a basis to estimate the number of vehicles sold in the U.S., which comes out to 766,478.
View narrative
US$177.19
FV
74.2% overvalued
intrinsic discount
14.36%
Revenue growth p.a.
Set Fair Value
113
users have liked this narrative
18
users have commented on this narrative
28
users have followed this narrative
9 months ago
author updated this narrative
Amazon.com
GO
Goran_Damchevski
Equity Analyst
Capital Intensity, Trade Headwinds and Maturity Won't Hinder Earnings Growth
Key Takeaways Core retail business facing limited expansion room, already has a significant market share in the U.S. Ad and streaming businesses are growing and have the potential to be major drivers of future growth. The ad business is well-positioned to capitalize on the growth of e-commerce.
View narrative
US$151.21
FV
41.4% overvalued
intrinsic discount
7.20%
Revenue growth p.a.
Set Fair Value
51
users have liked this narrative
10
users have commented on this narrative
30
users have followed this narrative
9 months ago
author updated this narrative
NVIDIA
GO
Goran_Damchevski
Equity Analyst
An Oversupply Of Compute Power Will See Margins Recede
Key Takeaways NVIDIA facing challenges, 30% data center market share at risk from chiplets AMD, Samsung, Intel entering GPU manufacturing race at cheaper price points Largest customers producing own chips, limits market for NVIDIA Generative AI cloud solutions introduces revenue cannibalization risk Gaming market revenue share at risk of stagnating Catalysts Company Catalysts Accelerating GPU Performance Will Reduce Profitability There is an argument to be made that the rapidly accelerating performance of GPUs will unlock markets in the next 3 to 5 years, but the same technology can lead to oversupply of compute power in the long term. As recently as 2021, there was a shortage of compute power for use cases like cryptocurrency mining, which was promoted as a key growth avenue.
View narrative
US$67.95
FV
162.3% overvalued
intrinsic discount
14.40%
Revenue growth p.a.
Set Fair Value
80
users have liked this narrative
16
users have commented on this narrative
49
users have followed this narrative
8 months ago
author updated this narrative
Advanced Micro Devices
RI
Richard_Bowman
Equity Analyst and Writer
Intense Competition Will Force AMD to Sacrifice Margins In Favor of R&D Spend
Key Takeaways Revenue growth will improve and then slow due to cyclical nature of chip demand There will be an inevitable plateau in AI investment Competition between CPU and GPU producers will intensify due massive long term potential This will result in very high R&D spend by all three, particularly AMD AMD’s revenue growth accelerates then falls into single digits by 2028 Catalysts Industry Catalysts CPU Demand Will Accelerate in 2024 and 2025, but Decelerate Again by 2028 CPU sales for the client segment is likely to accelerate rapidly as inventories have fallen and a new replacement cycle is overdue. Within the datacenter segment growth will be more measured.
View narrative
US$103.16
FV
69.0% overvalued
intrinsic discount
16.00%
Revenue growth p.a.
Set Fair Value
33
users have liked this narrative
2
users have commented on this narrative
14
users have followed this narrative
10 months ago
author updated this narrative
Apple
BA
Bailey
Equity Analyst
EU Regulations And Poor Emerging Market Strategy Will Erode Margins And Limit Sales Growth
Key Takeaways Over-reliance on new market penetration could prove to be unfruitful, while the world continues to grapple with cost-of-living pressures. Poor emerging market strategy could lead to failure in India and South America due to prohibitive costs.
View narrative
US$207.71
FV
2.3% undervalued
intrinsic discount
6.39%
Revenue growth p.a.
Set Fair Value
74
users have liked this narrative
18
users have commented on this narrative
36
users have followed this narrative
9 months ago
author updated this narrative
Value any company in seconds
Popular companies